From: Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy
 | HR | 1/HR | lover.95 | upper.95 | p value |
---|---|---|---|---|---|
Clinical data | |||||
groupe | 1.1561 | 0.8649 | 0.7079 | 1.8880 | p = 0.5620 |
age | 1.0479 | 0.9542 | 1.0242 | 1.0721 | p = 0.6081 |
gender | 1.1889 | 0.8410 | 0.7151 | 1.9767 | p = 0.5046 |
Methylation | |||||
MGMT | 0.5929 | 1.6866 | 0.3590 | 0.9789 | p = 0.041 |
p15 | 0.7883 | 1.2684 | 0.4065 | 1.5287 | p = 0.4816 |
p16 | 1.5724 | 0.6359 | 0.6735 | 3.6711 | p = 0.2954 |
Comparative genetic hybridization [CGH) | |||||
1q | 2.1684 | 0.4611 | 0.6683 | 7.0355 | p = 0.1974 |
amp4q12 | 2.3050 | 0.4338 | 1.1815 | 4.4965 | p = 0.01431 |
7 | 1.5579 | 0.6418 | 0.7591 | 3.1973 | p = 0.2267 |
amp7p12 | 1.4766 | 0.6771 | 0.8132 | 2.6813 | p = 0.2002 |
9p | 1.0812 | 0.9248 | 0.6633 | 1.7626 | p = 0.7538 |
10 | 1.0692 | 0.9352 | 0.6536 | 1.7490 | p = 0.7897 |
10q | 0.8369 | 1.1948 | 0.4945 | 1.4162 | p = 0.5071 |
12q | 1.0097 | 0.9903 | 0.5659 | 1.8015 | p = 0.9737 |
13 | 0.6853 | 1.4591 | 0.4169 | 1.1264 | p = 0.1361 |
17 | 1.0081 | 0.9919 | 0.5704 | 1.7816 | p = 0.9778 |
20 | 1.4714 | 0.6796 | 0.8380 | 2.5835 | p = 0.1787 |
22 | 1.0570 | 0.9459 | 0.5908 | 1.8912 | p = 0.8515 |